These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15247557)
1. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1041-50. PubMed ID: 15247557 [TBL] [Abstract][Full Text] [Related]
2. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451 [TBL] [Abstract][Full Text] [Related]
3. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine. Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587 [TBL] [Abstract][Full Text] [Related]
4. Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. Naisbitt DJ; Vilar FJ; Stalford AC; Wilkins EG; Pirmohamed M; Park BK AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1929-38. PubMed ID: 11153075 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433 [TBL] [Abstract][Full Text] [Related]
6. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. Sanderson JP; Naisbitt DJ; Farrell J; Ashby CA; Tucker MJ; Rieder MJ; Pirmohamed M; Clarke SE; Park BK J Immunol; 2007 May; 178(9):5533-42. PubMed ID: 17442935 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. Abouraya M; Sacco JC; Kahl BS; Trepanier LA Br J Clin Pharmacol; 2011 Apr; 71(4):566-74. PubMed ID: 21204907 [TBL] [Abstract][Full Text] [Related]
8. The effect of cimetidine on the formation of sulfamethoxazole hydroxylamine in patients with human immunodeficiency virus. Lehmann DF; Newman N; Morse PD J Clin Pharmacol; 1998 May; 38(5):463-6. PubMed ID: 9602961 [TBL] [Abstract][Full Text] [Related]
9. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Lenton KJ; Sané AT; Therriault H; Cantin AM; Payette H; Wagner JR Am J Clin Nutr; 2003 Jan; 77(1):189-95. PubMed ID: 12499341 [TBL] [Abstract][Full Text] [Related]
10. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233 [TBL] [Abstract][Full Text] [Related]
11. Guinea pig ascorbate status predicts tetrahydrobiopterin plasma concentration and oxidation ratio in vivo. Mortensen A; Hasselholt S; Tveden-Nyborg P; Lykkesfeldt J Nutr Res; 2013 Oct; 33(10):859-67. PubMed ID: 24074744 [TBL] [Abstract][Full Text] [Related]
12. Glutathione, cysteine, and ascorbate concentrations in clinically ill dogs and cats. Viviano KR; Lavergne SN; Goodman L; Vanderwielen B; Grundahl L; Padilla M; Trepanier LA J Vet Intern Med; 2009; 23(2):250-7. PubMed ID: 19143933 [TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Carr A; Tindall B; Penny R; Cooper DA Clin Exp Immunol; 1993 Oct; 94(1):21-5. PubMed ID: 8403509 [TBL] [Abstract][Full Text] [Related]
15. Time-course of toxicity of reactive sulfonamide metabolites. Rieder MJ; Krause R; Bird IA Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180 [TBL] [Abstract][Full Text] [Related]
16. Erythrocyte Ascorbate Is a Potential Indicator of Steady-State Plasma Ascorbate Concentrations in Healthy Non-Fasting Individuals. Pullar JM; Dunham S; Dachs GU; Vissers MCM; Carr AC Nutrients; 2020 Feb; 12(2):. PubMed ID: 32041092 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection. Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715 [TBL] [Abstract][Full Text] [Related]
18. Ascorbate and dehydroascorbate measurements in aqueous solutions and plasma determined by gas chromatography-mass spectrometry. Deutsch JC; Kolhouse JF Anal Chem; 1993 Feb; 65(4):321-6. PubMed ID: 8439008 [TBL] [Abstract][Full Text] [Related]
19. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. May JM; Qu ZC; Whitesell RR; Cobb CE Free Radic Biol Med; 1996; 20(4):543-51. PubMed ID: 8904295 [TBL] [Abstract][Full Text] [Related]
20. Nitroso-redox status and vascular function in marginal and severe ascorbate deficiency. Garcia-Saura MF; Saijo F; Bryan NS; Bauer S; Rodriguez J; Feelisch M Antioxid Redox Signal; 2012 Oct; 17(7):937-50. PubMed ID: 22304648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]